Overview
Chemotherapy, Vaccine Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Multiple Myeloma
Status:
Completed
Completed
Trial end date:
0000-00-00
0000-00-00
Target enrollment:
0
0
Participant gender:
Both
Both
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Vaccines made from a person's cancer cells may make the body build an immune response to kill cancer cells. Peripheral stem cell transplantation may be able to replace immune cells that were destroyed by chemotherapy. Combining chemotherapy with vaccine therapy and peripheral stem cell transplantation may be effective in treating multiple myeloma. PURPOSE: Phase I/II trial to study the effectiveness of chemotherapy followed by vaccine therapy and peripheral stem cell transplantation in treating patients who have newly diagnosed multiple myeloma.Phase:
Phase 1/Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer CenterCollaborator:
National Cancer Institute (NCI)Treatments:
VaccinesLast Updated:
2014-05-01
Criteria
DISEASE CHARACTERISTICS:- Newly diagnosed multiple myeloma
- More than 30% bone marrow involvement
- Eligible for autologous peripheral blood stem cell transplantation
PATIENT CHARACTERISTICS:
Age:
- 18 to 70
Performance status:
- ECOG 0-2
Life expectancy:
- Not specified
Hematopoietic:
- Absolute neutrophil count greater than 500/mm^3
- Platelet count greater than 30,000/mm^3
Hepatic:
- Bilirubin less than 3 times normal
- AST/ALT less than 3 times normal
Renal:
- Not specified
Other:
- Not pregnant
- HIV negative
- No prior or active autoimmune disease
- No other prior malignancy within the past 5 years
- No major active medical or psychosocial problems
PRIOR CONCURRENT THERAPY:
Biologic therapy:
- See Disease Characteristics
Chemotherapy:
- No more than 1 prior course of chemotherapy
Endocrine therapy:
- Not specified
Radiotherapy:
- Concurrent local radiotherapy allowed
Surgery:
- Not specified